Pasar al contenido principal

PAPEL DEL COACTIVADOR PGC-1BETA EN TEJIDO ADIPOSO BLANCO Y SU CONTRIBUCION AL DESARROLLO DE LA OBESIDAD Y LA DIABETES DE TIPO 2

BES-2009-013411

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Formación de Recursos Humanos de Investigación
Subprograma Subprograma de Formación de Personal Investigador (FPI)
Convocatoria Contratos Predoctorales
Año convocatoria 2009
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Formación e Incorporación de Investigadores
Centro beneficiario FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance

  • Arce Cerezo, Altamira
  • Garcia, Miquel|||0000-0002-1602-4993
  • Rodríguez-Nuevo, Aida|||0000-0002-4233-8398
  • Crosa-Bonell, Mireia
  • Enguix, Natàlia|||0000-0002-7873-902X
  • Peró, Albert
  • Muñoz-Martínez, S.|||0000-0003-0663-0575
  • Roca Lecha, Carles|||0000-0002-3744-3089
  • Ramos Gonzalez, David|||0000-0002-8574-218X
  • Franckhauser, Sylvie|||0000-0001-5255-1224
  • Elias Puigdomenech, Ivet|||0000-0002-1304-9597
  • Ferre, Tura|||0000-0001-9713-0829
  • Pujol i Altarriba, Anna|||0000-0002-3484-598X
  • Ruberte Paris, Jesús|||0000-0003-1540-1432
  • Villena, Josep A.|||0000-0002-2200-2985
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
  • Riu, Efrén|||0000-0002-2574-3578
High-Mobility-Group-A1 (HMGA1) proteins are non-histone proteins that regulate chromatin structure and gene expression during embryogenesis, tumourigenesis and immune responses. In vitro studies suggest that HMGA1 proteins may be required to regulate adipogenesis. To examine the role of HMGA1 in vivo, we generated transgenic mice overexpressing HMGA1 in adipose tissues. HMGA1 transgenic mice showed a marked reduction in white and brown adipose tissue mass that was associated with downregulation of genes involved in adipogenesis and concomitant upregulation of preadipocyte markers. Reduced adipogenesis and decreased fat mass were not associated with altered glucose homeostasis since HMGA1 transgenic mice fed a regular-chow diet exhibited normal glucose tolerance and insulin sensitivity. However, when fed a high-fat diet, overexpression of HMGA1 resulted in decreased body-weight gain, reduced fat mass, but improved insulin sensitivity and glucose tolerance. Although HMGA1 transgenic mice exhibited impaired glucose uptake in adipose tissue due to impaired adipogenesis, the increased glucose uptake observed in skeletal muscle may account for the improved glucose homeostasis. Our results indicate that HMGA1 plays an important function in the regulation of white and brown adipogenesis in vivo and suggests that impaired adipocyte differentiation and decreased fat mass is not always associated with impaired whole-body glucose homeostasis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Rosiglitazone-Induced Mitochondrial Biogenesis in White Adipose Tissue Is Independent of Peroxisome Proliferator-Activated Receptor γ Coactivator-1α

  • Pardo, Rosario
  • Enguix, Natàlia|||0000-0002-7873-902X
  • Lasheras Márquez, Jaime
  • Feliu Albiñana, Juan Emilio|||0000-0003-1183-7597
  • Kralli, Anastasia
  • Villena, Josep A.|||0000-0002-2200-2985
Thiazolidinediones, a family of insulin-sensitizing drugs commonly used to treat type 2 diabetes, are thought to exert their effects in part by promoting mitochondrial biogenesis in white adipose tissue through the transcriptional coactivator PGC-1α (Peroxisome Proliferator-Activated Receptor γ Coactivator-1α). To assess the role of PGC-1α in the control of rosiglitazone-induced mitochondrial biogenesis, we have generated a mouse model that lacks expression of PGC-1α specifically in adipose tissues (PGC-1α-FAT-KO mice). We found that expression of genes encoding for mitochondrial proteins involved in oxidative phosphorylation, tricarboxylic acid cycle or fatty acid oxidation, was similar in white adipose tissue of wild type and PGC-1α-FAT-KO mice. Furthermore, the absence of PGC-1α did not prevent the positive effect of rosiglitazone on mitochondrial gene expression or biogenesis, but it precluded the induction by rosiglitazone of UCP1 and other brown fat-specific genes in white adipose tissue. Consistent with the in vivo findings, basal and rosiglitazone-induced mitochondrial gene expression in 3T3-L1 adipocytes was unaffected by the knockdown of PGC-1α but it was impaired when PGC-1β expression was knockdown by the use of specific siRNA. These results indicate that in white adipose tissue PGC-1α is dispensable for basal and rosiglitazone-induced mitochondrial biogenesis but required for the rosiglitazone-induced expression of UCP1 and other brown adipocyte-specific markers. Our study suggests that PGC-1α is important for the appearance of brown adipocytes in white adipose tissue. Our findings also provide evidence that PGC-1β and not PGC-1α regulates basal and rosiglitazone-induced mitochondrial gene expression in white adipocytes.